Table 4 Glycemic control, insulin and incretin secretion.
NGT | T2D | |||||
|---|---|---|---|---|---|---|
Pre | 1 y | Late | Pre | 1 y | Late | |
Glycemic control | ||||||
HbA1c (mmol/mol) | 36 ± 0.7 | 35 ± 0.7* | 36 ± 0.9 | 52 ± 2‡‡ | 38 ± 1**,‡ | 42 ± 2**,†,‡ |
Fasting Glucose (mmol/L) | 5.3 ± 0.1 | 4.9 ± 0.1** | 4.9 ± 0.1** | 8.8 ± 0.4‡‡ | 5.8 ± 0.3**, ‡‡ | 6.0 ± 0.3**, ‡ |
Peak Glucose (mmol/L) | 7.6 ± 0.3 | 9.2 ± 0.3** | 9.5 ± 0.4** | 14.3 ± 0.8‡‡ | 11.9 ± 0.6*,‡‡ | 12.7 ± 0.7‡‡ |
Postprandial nadir glucose (mmol/L) | 5.3 ± 0.2 | 3.9 ± 0.2** | 3.8 ± 0.2** | 9.2 ± 0.5‡‡ | 5.5 ± 0.3**,‡‡ | 6.2 ± 0.5**,‡‡ |
IAUC Glucose (mol × min/L) | ‡‡ | *, ‡‡ | ‡‡ | |||
Cohort 1 (0–180 min) | 80 ± 21 | 81 ± 18 | 94 ± 40 | 367 ± 40 | 239 ± 26 | 301 ± 49 |
Cohort 2 (0–120 min) | 244 ± 36 | 271 ± 58 | 331 ± 65 | 665 ± 74 | 564 ± 66 | 667 ± 63 |
Insulin secretion | ||||||
Fasting Insulin (pmol/L) | 88 ± 8 | 34 ± 4** | 36 ± 4** | 139 ± 16‡ | 46 ± 7** | 54 ± 7** |
Peak Insulin (pmol/L) | 671 ± 88 | 889 ± 94 | 868 ± 109 | 507 ± 62 | 625 ± 89*,‡ | 627 ± 94 |
IAUC Insulin (nmol × min/L) | ||||||
Cohort 1 (0–180 min) | 32 ± 3 | 38 ± 5 | 32 ± 5 | 32 ± 5 | 29 ± 4 | 25 ± 4 |
Cohort 2 (0–120 min) | 60 ± 19 | 56 ± 20 | 67 ± 22 | 28 ± 7 | 36 ± 11 | 45 ± 13 |
Fasting C-peptide (pmol/L) | 1054 ± 56 | 597 ± 43** | 588 ± 37** | 1415 ± 111‡ | 746 ± 84** | 822 ± 88**,‡ |
Peak C-peptide (pmol/L) | 3620 ± 241 | 4434 ± 340* | 4270 ± 364 | 3180 ± 263 | 3365 ± 339 | 3490 ± 364 |
IAUC C-peptide (nmol × min/L) | * | ‡ | ** | ** | ||
Cohort 1 (0–180 min) | 178 ± 14 | 223 ± 23 | 211 ± 23 | 157 ± 18 | 183 ± 19 | 180 ± 20 |
Cohort 2 (0–120 min) | 286 ± 47 | 316 ± 71 | 341 ± 63 | 159 ± 30 | 264 ± 43 | 288 ± 48 |
Basal ISR (pmol × min−1 × kg−1) | 2.6 ± 0.13 | 1.8 ± 0.11** | 1.7 ± 0.10** | 3.3 ± 0.22‡ | 2.1 ± 0.20** | 2.2 ± 0.21**, ‡ |
IAUC ISR (pmol × kg−1) | * | * | ‡ | ** | ** | |
Cohort 1 (0–180 min) | 510 ± 49 | 762 ± 103 | 676 ± 89 | 427 ± 46 | 582 ± 69 | 603 ± 78 |
Cohort 2 (0–120 min) | 974 ± 149 | 1238 ± 279 | 1262 ± 247 | 528 ± 95 | 980 ± 140 | 1008 ± 202 |
Incretins (Cohort 1) | ||||||
Basal GLP-1 (pmol/L) | 12 ± 1 | 9 ± 1 | 12 ± 1† | 12 ± 1 | 10 ± 1 | 15 ± 2† |
Postprandial GLP-1 (pmol/L), T = 45 min | 15 ± 1 | N/A | 64 ± 10** | 16 ± 2 | N/A | 72 ± 9** |
Basal GIP (pmol/L) | 7 ± 1 | 7 ± 1 | 8 ± 1 | 10 ± 2 | 9 ± 1 | 10 ± 1 |
Postprandial GIP (pmol/L), T = 60 min | 68 ± 9 | 37 ± 3* | 45 ± 5** | 65 ± 4 | 46 ± 2* | 52 ± 4* |